Insider Trading & Ownership - Myrexis Inc. (MYRX)

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Myrexis Inc.
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2021-08-13
Sale
2021-08-17
6:07 pm
ENZON PHARMACEUTICALS INC.ENZNCOUCHMAN JONATHAN
Couchman Family Fund
Xstelos Corp.
Myrexis Inc.
10% Owner
107,500$0.3898$41,9047,393,954
(Indirect)
View
2020-08-24
Sale
2020-08-26
4:49 pm
ENZON PHARMACEUTICALS INC.ENZNCOUCHMAN JONATHAN
Couchman Family Fund
Xstelos Corp.
Myrexis Inc.
Harper Brian James
HARPER ASSET MANAGEMENT LLC
Pearce Michael Cooper
10% Owner
77,100$0.18596$14,3389,441,648
(Indirect)
View
2020-08-05
Purchase
2020-08-06
4:23 pm
ENZON PHARMACEUTICALS INC.ENZNCOUCHMAN JONATHAN
Couchman Family Fund
Xstelos Corp.
Myrexis Inc.
Harper Brian James
HARPER ASSET MANAGEMENT LLC
Pearce Michael Cooper
10% Owner
506,292$0.2$101,2589,518,748
(Indirect)
View
2020-03-13
Purchase(A)
2020-03-31
6:34 pm
ENZON PHARMACEUTICALS INC.ENZNCOUCHMAN JONATHAN
Couchman Family Fund
Xstelos Corp.
Myrexis Inc.
10% Owner
652,723$0.13985$91,2835,750,930
(Indirect
Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing

Ownership
2020-08-06
4:20 pm
N/A
N/A
ENZON PHARMACEUTICALS INC.ENZNCOUCHMAN JONATHAN
Couchman Family Fund
Xstelos Corp.
Myrexis Inc.
Harper Brian James
HARPER ASSET MANAGEMENT LLC
Pearce Michael Cooper
10% Owner
0$09,518,748
(Indirect)
View

Ownership
2020-03-31
6:30 pm
N/A
N/A
ENZON PHARMACEUTICALS INC.ENZNMyrexis Inc.
See Footnote 1
0$0250
(Direct)
View
(A) Indicate amendment filing.